We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more
– Part 2 of REFRαME-O1, the registration-directed study of luvelta for patients with platinum-resistant ovarian cancer (PROC), is open for enrollment – – Planned 50 patients in Dose-Optimization...
SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...
- Sutro highlighted luveltamab tazevibulin (luvelta) in a January 2024 investor webcast, describing the broad opportunity to address unmet needs in multiple FolRα-expressing cancers...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.42 | 12.3167155425 | 3.41 | 4.13 | 3.345 | 658900 | 3.64960282 | CS |
4 | -1.05 | -21.5163934426 | 4.88 | 5.275 | 3.3 | 791078 | 4.02420398 | CS |
12 | -0.95 | -19.8744769874 | 4.78 | 6.13 | 3.2 | 1008906 | 4.47715819 | CS |
26 | 1.05 | 37.7697841727 | 2.78 | 6.13 | 2.005 | 950956 | 4.00316102 | CS |
52 | -1.02 | -21.0309278351 | 4.85 | 6.13 | 2.005 | 707099 | 4.15089652 | CS |
156 | -16.91 | -81.5332690453 | 20.74 | 23.7 | 2.005 | 562061 | 7.10102508 | CS |
260 | -6.23 | -61.9284294235 | 10.06 | 28.3 | 2.005 | 427159 | 9.36379293 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions